Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 5602: VTX-0811, a first-in-class PSGL-1 blocking monoclonal antibody, repolarizes tumor associated macrophages and induces inflammation in the tumor microenvironment, leading to suppression of tumor growth in pre-clinical studies

Cancer Res (2022) 82 (12_Supplement): 5602.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal